Mycenax Biotech (ROCO:4726) Total Stockholders Equity : NT$1,897.5 Mil (As of Mar. 2025)

View and export this data going back to 2013. Start your Free Trial

What is Mycenax Biotech Total Stockholders Equity?

Mycenax Biotech's Total Stockholders Equity for the quarter that ended in Mar. 2025 was NT$1,897.5 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Mycenax Biotech's Book Value per Share for the quarter that ended in Mar. 2025 was NT$9.16. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Mycenax Biotech's Debt-to-Equity for the quarter that ended in Mar. 2025 was 0.52.

Mycenax Biotech Total Stockholders Equity Historical Data

The historical data trend for Mycenax Biotech's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mycenax Biotech Total Stockholders Equity Chart

Mycenax Biotech Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Stockholders Equity

Get a 7-Day Free Trial

1,211.67

1,906.67

3,105.58

2,447.19

2,023.48

Mycenax Biotech Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Total Stockholders Equity	Get a 7-Day Free Trial															2,318.15	2,227.87	2,096.65	2,023.48	1,897.52

Mycenax Biotech (ROCO:4726) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Mycenax Biotech's Book Value per Share for the quarter that ended in Mar. 2025 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(1897.519	-	0)	/	207.111
	=	9.16

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Mycenax Biotech's Debt-to-Equity for the quarter that ended in Mar. 2025 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(328.329	+	662.265)	/	1897.519
	=	0.52

Mycenax Biotech Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Mycenax Biotech's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Mycenax Biotech Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Mycenax Biotech Inc (ROCO:4726) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

No.66, Shengyi 2nd Road, 7th Floor, Hsinchu Science Park, Hsinchu County, Zhubei, TWN, 302041

Website

https://www.mycenax.com.tw

Mycenax Biotech Inc is a Taiwan-based biopharmaceutical company. It is engaged in the development and manufacture of biopharmaceutical products, specializing in mammalian and microbial cell-derived biologics. The company provides services for program evaluation/confirmation, cell line development, and construction, process development technology platforms, drug characterization analysis, the establishment of testing methods, and drug production in accordance with PIC/S GMP manufacturing standards.

Mycenax Biotech Headlines

No Headlines